KR101820928B1 - The Method and Apparatus for Dry Eye Syndrome Diagnosis and Targeted Theranostics by three dimensional recognization - Google Patents

Abstract

The present invention relates to an apparatus for diagnoses and treatments of dry eye syndrome, which can simultaneously diagnose and treat abnormalities of lacrimal gland and meibomian gland, causes of dry eye syndrome, and to a method thereof. The apparatus for diagnoses and treatments of dry eye syndrome comprises: a 3D scanner unit (10); a multi-wavelength light source module unit (110); a near infrared ray camera unit (120); a thermal infrared image camera unit (130); a display unit (140); and a control unit (150).

Description

TECHNICAL FIELD The present invention relates to a device for diagnosing dry eye syndrome and a method for diagnosing dry eye syndrome through stereoscopic recognition,

The present invention relates to a diagnosis and treatment of dry eye syndrome, and more particularly, to a diagnostic and therapeutic method for dry eye syndrome, Dry diagnostic target diagnostic apparatus and method thereof.

Inside the inner skin of the human eyelid there is Myung-spring, which releases the fat layer for tear film, and lacrimal gland, which releases water containing tears. The myospasm has a length of 3-4 mm, there are about 31 glands in the upper eyelid and about 26 glands in the lower eyelid.

The tear film formed by the fat and tears secreted from the myo spring and lacrimal glands is formed into a continuous and complex multilayered structure composed of water, inorganic salts, carbohydrates, lipids and proteins to cover the entire exposed eye surface to protect the eyeball, And performs nutrition and antibacterial action.

In this case, when the quality and amount of the tear film are changed, dry eye syndrome (DES), which causes the eyes to dry, is generated, which leads to inconvenience. In severe cases, inflammation . In general, dry eye syndrome is a high incidence in women over 50 years old, but it affects men and women of all ages. In the United States, 3.2 million men aged 50 or older and 1.68 million men aged 50 or older were affected by dry eye syndrome.

Actually, about 86% of dry eye syndrome is caused by Meibomian Gland Dysfunction. Specifically, if the My spring is clogged or thickened and does not produce or release lipid, it affects the stability and quality of the tear film. Examples of such myalgia dysfunction include low fat delivery and obstructive myalobular dysfunction, high delivery rates, and seborrheic dysfunction. In the case of low fat delivery and occlusive myalgia dysfunction, moisture in the tear film is easily evaporated due to fat deficiency, resulting in dry eyes. And in case of high delivery rate, seborrheic dysfunction, my spring is over secretion of fat, causing inflammation reaction of eyeball surface, which causes eye inflammation. If these dry eye syndromes are not treated for a long time, they can cause complications.

However, in the case of the prior art, the diagnosis of dry eye syndrome is made by measuring the tear secretion test (Schirmer test), eye blinking speed and tear osmotic pressure for a certain period of time, . In the case of treatment, artificial tear prescription is the main part, and the treatment is performed through other drugs, eyelid scrub, warm / pressure and omega 3, and diagnosis and treatment of myalgia are not performed.

Therefore, it is necessary to diagnose and treat dry eye syndrome with the diagnosis and treatment of myalgia.

Accordingly, Korean Patent Laid-Open No. 10-2016-0146220 discloses a technique in which two infrared light sources are alternately inspected to synthesize a photographed image, whereby the image portion due to excessive reflection or the light irradiation is weakened, And then calculating an area and a micronucleus number of myos spring by image processing.

However, in the diagnosis of myalgia dysfunction, in the case of the invention disclosed in the above-mentioned prior arts, the diagnosis of myalgia dysfunction is made by generating mivoglossy and calculating the area and the number of micronucleus of myospasm, , It is suggested that the amount of lipid emission is sufficient, or that there is no particular problem in terms of structure or arrangement, but there is a problem that the opening of the secretion is closed, Because of the inability to diagnose, there is a problem that it is not enough to use it as a basis for treatment.

In addition, the diagnosis procedure is complicated and the accuracy is low, such as whether the problem of dry eye syndrome is a problem of lacrimal gland, the area of my spring is insufficient, or whether it is a problem of obstructive my spring.

Next, micro-acupuncture treatment, hyperthermia treatment, and the like have been used as methods for treating myalgia.

The micro-acupuncture treatment method is a treatment technique using a micro-needle to drill the entrance of the myocardium, but it has a problem that it can further damage the my spring.

In the case of myo spring clogging, when the myo spring is clogged, the oil is melted using the warming and then massage or the physical stimulation with the eyelid force is used to discharge the oil. However, the apparatus for treating hyperthermia is expensive, One-time treatment costs are also very expensive and have low accessibility. Also, since the temperature standard in hyperthermia is not based on an accurate diagnosis of myalgia dysfunction, patients may feel uncomfortable during treatment due to high temperature.

Korean Patent Publication No. 10-2016-0146220

SUMMARY OF THE INVENTION Accordingly, the present invention has been made to solve the above-mentioned problems occurring in the prior art, and it is an object of the present invention to provide an apparatus and method for diagnosing and treating dry eye syndromes capable of simultaneously diagnosing and treating abnormalities of lacrimal gland and meibomian gland, And to provide such a method.

In order to achieve the above object, the apparatus for diagnosing dry eye syndrome according to the present invention comprises:

A 3D scanner unit 10 for projecting scanning light on a facial plane on which an eyeball is located for target diagnosis and treatment of dry eye syndrome, and then capturing a pattern image of a local target area to be irradiated with the diagnostic and treatment light source;

A multi-wavelength light source unit 111 for selecting a wavelength of a light source to perform diagnosis or treatment of My spring radiation, varying intensity of a selected wavelength and outputting light of a selected wavelength to the local target area in a noncontact manner, And a lacrimal gland diagnostic probe for detecting light reflected after passing through the biological tissue where the lacrimal gland is located and passing through the eye lumen, A multi-wavelength light source module unit 110 having a light source module 113;

A near infrared ray camera unit 120 for photographing a near infrared ray image of the eyelid irradiated with the light;

A thermal imaging camera unit 130 for photographing a thermal image of the eyelid to detect the temperature of the eye during the treatment of the myospasm;

A display unit 140 for outputting an image of the eyelids and control information; And

Generating a 3D image including a localized region to which the diagnostic and treatment light source is to be irradiated after receiving the pattern image for diagnosis and treatment and generating a 3D image including a region corresponding to the upper and lower eyelids in the 3D image for diagnosis of dry eye syndrome Wavelength light source module unit 110 and controls the wavelength and intensity of the output light of the multi-wavelength light source module unit 110 to be emitted to the target area. The optical signal received by the lacrimal gland diagnosis probe unit 113 is analyzed, And detects a region corresponding to the upper and lower eyelids as a local target region in the 3D image, and measures the wavelength and the intensity of the output light of the multi-wavelength light source unit 111 And a control unit (150) for irradiating the local target area to treat dry eye syndrome.

The multi-wavelength light source unit (111)

To diagnose the tear secretion of the lacrimal gland, a diagnostic light source (laser diode (LD) or light emitting diode (LED)) that outputs light with a high water absorption rate (eg 970 ~ 980nm) (Laser diode (LD) or light-emitting diode (LED)) for the diagnosis and treatment of myxomas, which outputs light having a high absorption rate (eg, 920 to 930 nm) for lipids for lipids .

The probe unit 113 includes:

A light irradiating unit 114 for irradiating the light of the multi-wavelength light source unit 111 with the lid of the lacrimal gland and irradiating the lacrimal gland diagnosis light, and a light detecting unit 115 for detecting light reflected from the eyelid, In the case where the light source of the multi-wavelength light source unit 111 is a light source of a beam combiner type, an optical cable 112 for guiding the emitted light to directly contact the eyelid where the lacrimal gland is placed is connected to the support base 1 for supporting the head, Type light source, the light source may be positioned on the support 1 for supporting the head so that it can be directly irradiated.

The probe unit 113 includes:

The light irradiation unit 114 and the light detection unit 115 are spaced 5 to 10 mm apart so that the light irradiation unit 114 and the light detection unit 115 are installed to be movable along the rail 2 from the support base 1 supporting the head so as to be selectively applied to both eyes. .

The control unit 150,

In the diagnosis of lacrimal gland, the lacrimal gland diagnosis light may be irradiated, and at the time of diagnosis of myomalgia, the multi-wavelength light source unit 111 may be controlled so as to be irradiated with an output power of 10 mW or less .

The control unit 150,

In the treatment of my spring spring, a light source having a wavelength for treating myalbumin is maintained at an output of 10 to 100 mW so that the temperature of the eyelid region to be treated is maintained at 40 to 45 ° C by using an image captured by the thermal imaging camera unit 130 Wavelength light source unit 111 so as to control the output in a range where the multi-wavelength light source unit 111 is controlled.

Also, the control unit 150 may be configured to,

Based on the diagnosis result of Myungsoom in the treatment light, it is possible to select the pulse wave to output continuous wave or instantaneous high output power. Lt; / RTI >

In order to accomplish the above object, the present invention provides a method for diagnosing dry eye syndrome through stereoscopic recognition,

A multi-wavelength light source module unit 110 having a 3D scanner unit 10, a multi-wavelength light source unit 111 and a probe unit 113, a near-infrared ray camera unit 120, a thermal imaging camera unit 130, a display unit 140 ) And a controller (150), the method comprising the steps of:

The pattern image is generated and transmitted after the scanning light of the 3D scanner unit 10 is projected on the entire face of the face where the eyeball is located and the pattern image is received by the control unit 150 and the pattern image is received by the upper and lower eyelids A 3D local target area image generating step (SlOO) for generating a 3D image including a target area;

The control unit 150 controls the light source for myuxiliary eye diagnosis of the multi-wavelength light source module unit 110 in a state in which the eyelid is wrapped around the patient so that the function of the myal spring can be diagnosed in advance, A screening diagnostic process S200 for irradiating light having a wavelength of 920 to 930 nm to the local target area and displaying the eyelid image of the patient photographed through the near infrared ray camera unit 120 on the display unit 140;

In the case where the myalobiliary function deterioration is detected in the near infrared ray eyelid image displayed on the display unit 140 through the screening diagnosis process (S200), the controller 150 controls the multi- (LD or LED) of the light source module unit 110 to irradiate a light source having a wavelength of 920 to 930 nm with an output of 10 mW or less in the local target area of the inverted eyelid of the patient, and the near infrared ray camera unit 120 (I.e., structured image), the light of all wavelengths of the near-infrared band embedded in the multi-wavelength module is irradiated to each of the near infrared ray camera units 120 according to different wavelengths irradiated thereto, After detecting the dry eye syndrome, the lesion area is detected, and the functional image is implemented through the photographed image, My bomsaem detailed diagnostic process of displaying the functional image is displayed an image of the eyelids combined patient part (140) (S300); And

The control unit 150 detects a region corresponding to the eyelid region detected in the 3D image as a local target region and controls the light source for treating mybar spring in the multi-wavelength light source module unit 110 for treatment of myalgia deficiency Myo-spring is a non-contact type focused intensive treatment of light sources with high absorption (eg, 920 to 930nm) on the eyelid of the local target area of the patient with eyes closed, in the range of tens to hundreds of mW. Spring spring treatment process (S500); And

The temperature of the eyelid of the patient whose eyes are closed by the thermal imaging camera unit 130 is monitored by the thermal imaging camera during the course of the mybalance treatment process (S500), and the controller 150 monitors the temperature of the skin (S600) for controlling the output power of the light source for treating mybar spring so as to maintain the temperature at 40 to 45 ° C.

The method for diagnosing dry eye syndrome through stereoscopic recognition comprises:

The controller 150 controls the light source for diagnosing the lacrimal gland of the multi-wavelength light source module unit 110 at the location of the lacrimal gland of the patient, ) Is placed in the vicinity of the lacrimal gland of the patient and is brought into direct contact with the vicinity of the lacrimal gland through the probe unit 113 to irradiate the lacrimal gland diagnostic light source with an output of several mW or less and the light reflected through the tissue near the lacrimal and lacrimal glands The control unit 150 detects the amount of light detected by the tear absorbing rate and displays the amount of tears in the lacrimal gland as a percentage based on the steady state (S400) for diagnosing the function of the lacrimal gland (S400).

The present invention having the above-described constitution accurately diagnoses the cause of dry eye syndrome by accurately diagnosing the function of the lacrimal gland and the function of the myo-spring deficiency, detects the light source area for diagnosis and treatment as a local target area, By irradiating the treatment laser to the eyelid area where the myo spring is located, the eye can be safely treated without damage to the eye.

In addition, the present invention uses light having an output of several mW (i.e., 10 mW or less) at the time of diagnosing myalgia dysfunction, and uses light having a power of several mW By performing the treatment using a light source for diagnosis and treatment of My spring spring whose output is controlled so as to have a temperature ranging from 40 to 45 ° C in a range of several tens to several tens to several hundreds of mW, Or pain, thereby making it possible to significantly improve the comfort and safety of the diagnosis and treatment of the patient.

FIG. 1 is a block diagram of an apparatus for diagnosing and treating dry eye syndrome through stereoscopic recognition according to an embodiment of the present invention. FIG.
2 is a view showing an example of a multi-wavelength light source that can be used in the multi-wavelength light source portion.
3 is a diagram showing the characteristics of a constituent light source of the multi-wavelength light source unit 111. Fig.
4 is a flowchart showing a process of a dry eye diagnosis and treatment method according to an embodiment of the present invention.
5 is a diagram showing a screening diagnostic process (S200);
FIG. 6 is a diagram showing a structural image during the detailed diagnosis process (S300) of my spring. FIG.
FIG. 7 is a diagram showing a functional image through several near-infrared wavelengths in addition to the structural image of FIG. 6 in the detailed diagnosis process of my spring (S300);
Fig. 8 is a diagram showing degradation of My-spring function. Fig.
Figure 9: Thermographic image for monitoring the temperature by the treatment light source during myalgia dysfunction treatment.

In the following description of the present invention, detailed description of known functions and configurations incorporated herein will be omitted when it may make the subject matter of the present invention rather unclear.

The embodiments according to the concept of the present invention can be variously modified and can take various forms, so that specific embodiments are illustrated in the drawings and described in detail in the specification or the application. It is to be understood, however, that the intention is not to limit the embodiments according to the concepts of the invention to the specific forms of disclosure, and that the invention includes all modifications, equivalents and alternatives falling within the spirit and scope of the invention. Also, the word "exemplary" is used herein to mean "serving as an example, instance, or illustration." Any aspect described herein as "exemplary " is not necessarily to be construed as preferred or advantageous over other aspects.

It is to be understood that when an element is referred to as being "connected" or "connected" to another element, it may be directly connected or connected to the other element, . On the other hand, when an element is referred to as being "directly connected" or "directly connected" to another element, it should be understood that there are no other elements in between. Other expressions that describe the relationship between components, such as "between" and "between" or "neighboring to" and "directly adjacent to" should be interpreted as well.

The terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. The singular expressions include plural expressions unless the context clearly dictates otherwise. In this specification, the terms "comprises ", or" having ", or the like, specify that there is a stated feature, number, step, operation, , Steps, operations, components, parts, or combinations thereof, as a matter of principle.

Hereinafter, the present invention will be described in more detail with reference to the accompanying drawings showing embodiments of the present invention.

FIG. 1 is a block diagram of an apparatus for diagnosing and treating a dry eye syndrome according to an embodiment of the present invention, and FIG. 2 is a diagram illustrating an example of a multi-wavelength light source that can be used in a multi-wavelength light source unit.

1, the dry eye syndrome diagnosis and treatment apparatus 100 includes a 3D scanner unit 10, a multi-wavelength light source module unit 110, a near-infrared ray camera unit 120, a thermal imaging camera unit 130, a display unit 140 And a control unit 150. [0033]

The 3D scanner unit 10 includes a scanning light source unit 23A having a scanning light emitting end 23 and a camera unit 20-2 having a scanning light inlet end 24, And a pattern image for the eyelid region is generated and transmitted to the controller 150 in order to detect a local target area to which the light source should be irradiated for diagnosing and treating dry eye. The scanning light emitting end 23 and the scanning light inflow end 24 may be disposed at appropriate positions for pattern image formation of eyelids such as upper and lower portions of both the probe units 113.

1 and 2, the multi-wavelength light source module unit 110 includes a multi-wavelength light source unit 111 for varying the wavelength and intensity of the light source so as to perform diagnosis and treatment of myo spring for diagnosing or treating dry eye syndrome, And a probe unit 113 for irradiating light to the eyelid for detecting the lacrimal gland and detecting the reflected light.

The multi-wavelength light source unit 111 includes a multi-wavelength light source (a beamcombiner A, a multi-wavelength light source and ultra-small chip L) in which light sources for outputting light having an absorption wavelength of a specific material are arranged in a number suited for diagnostic and therapeutic purposes, . Specifically, the multi-wavelength light source (A, L) is an example for diagnosing the tear secretion of the lacrimal gland, and is an example of a diagnostic light source for diagnosing and treating the lacrimal gland, which outputs light having a wavelength of 970 to 980 nm, And a multi-wavelength light source for diagnosing and treating MySpace, which outputs light having a wavelength of 920 to 930 nm which is maximally absorbed from the lipid of the spring glands. In the above-described configuration, the beam combiner A is configured such that a plurality of LEDs or LDs are arranged radially so as to irradiate light to the central portion, thereby increasing the light output. The multi-wavelength light source microchip (L) has the form of a chip in which a plurality of LEDs or LDs having different wavelengths are arranged.

3 is a view showing an example of characteristics according to the wavelengths of the multi-wavelength light source constituting the multi-wavelength light source unit 111. FIG. As shown in FIG. 3, the multi-wavelength light sources A and L may include a plurality of light sources (LDs or LEDs) having an absorption wavelength in the tissue according to an infrared wavelength to be suitable for diagnosis and treatment. At this time, the output of each light source (LD or LED) is configured so that its output is controlled by the control unit 150 in accordance with the treatment and treatment.

The above-described multi-wavelength light sources A and L arranged by arranging a plurality of light sources (LD or LED) having a specific wavelength have one wavelength-selectable light source for selecting and outputting light of a wavelength required for treatment and diagnosis .

The probe unit 113 includes a light irradiating unit 114 for irradiating light of the multi-wavelength light source unit 111 with the lacrimal gland of the eye and irradiating the light, and a photodetector PD for detecting light reflected through the lacrimal gland tissue, And a photodetector 115 composed of a photodetector. The multi-wavelength light source unit 111 and the light detection unit 115 may be connected to the optical cable 112 for guiding the light and may be configured to irradiate or detect the light, or to directly irradiate or detect the light.

At this time, the light source having a wavelength of 920 to 930 nm penetrates into the depth of about 3 mm from the eyelid skin and is then reflected in a banana shape for detection of the lacrimal gland dysfunction. Therefore, the light irradiation unit 114 and the light detection unit 115 For example, 5 to 10 mm apart. The probe unit 113 having the above-described structure can be installed so as to be movable along the rail 2 in the support 1 supporting the head so as to be selectively applied to both eyes.

The near infrared ray camera unit 120 is configured to photograph a near infrared ray image of a local target area of an eyelid closed with eyes in a screening diagnosis process in which light having a wavelength of 920 to 930 nm is irradiated to a local target area do. At this time, it is possible to diagnose a case where the light having a wavelength of 920 to 930 nm is absorbed by the lipid of my spring tears and the myospasm is lost, and in the detailed diagnosis process of my spring tears, the same wavelength is shifted from the inverted 3D local target eyelid Structural images of the spring glands are photographed, and when multiple wavelengths of the near infrared band are irradiated, functional images are also imaged by imaging the images. Especially in the detailed diagnosis process, myosampsia absorbs the wavelength for lipid to show white color, and when the fat is hardened, it becomes more bright white. It is possible to change the information about color through image processing and the implementation of functional image that can distinguish the difference of lipids in Mybus Spring. My Spring 's image does not appear in the damaged area of my spring' s ears, and it can diagnose abnormalities such as clogging or damage of my spring 's ears.

The thermal imaging camera unit 130 is configured to photograph the thermal image of the eyelid to detect the temperature of the eye during the treatment of the dry eye syndrome.

The display unit 140 includes a display device for outputting an image of the eyelids and control information.

After receiving the pattern image for diagnosis, the controller 150 generates a 3D image including an area to be illuminated by the light source, and generates a 3D image corresponding to the upper and lower eyelids Wavelength light source module unit 110 and adjusts the wavelength and intensity of the output light of the multi-wavelength light source module unit 110 to be emitted to the local target area, and the optical signal received by the lacrimal gland diagnosis probe unit 113 And detects a region corresponding to the upper and lower eyelids in the 3D image as a local target region and measures the wavelength and intensity of the output light of the multi-wavelength light source unit 111 The control is performed to diagnose or treat dry eye syndromes to treat dry eye syndromes by irradiating a local target area requiring the treatment. .

Specifically, the controller 150 drives light sources of different wavelengths according to the diagnoses of myalgia hypometabolism and abnormal diagnosis of lacrimal gland. In the case of myalgia function depression treatment, the controller 150 generates light having a wavelength of 920 to 930 nm The output of the light source (LD or LED) is controlled to be 10 mW or less so as to prevent the patient from feeling uncomfortable, such as a sense of warmth during diagnosis. In order to maintain the temperature of the skin at 40 to 45 DEG C, the temperature of the skin is detected through the thermal image captured by the thermal imaging camera unit 130, And the output of the light source for generating light is controlled to be in the range of tens to several hundreds of mW, thereby preventing heat or an image of the skin.

The controller 150 is configured to drive a light source that outputs light having a wavelength that is maximally absorbed in water (for example, 970 to 980 nm) when it is desired to diagnose degradation of the lacrimal gland. Also in this case, the light source is controlled so as to have a light output of 10 mW or less in order to prevent skin irritation such as a thermal feeling from being generated.

4 is a flowchart showing a process of a dry eye diagnosis and treatment method according to an embodiment of the present invention.

4, the method for diagnosis and treatment of dry eye syndrome includes the steps of generating a 3D local target image (S100), a screening diagnostic process (S200), a myaloscope detailed diagnostic process (S300), a tear gland diagnosis process (S400) (S500) and a skin temperature control process (S600).

In the 3D local target image generation process S100, a pattern image is generated and transmitted after the scanning light of the 3D scanner unit 10 is projected on the entire face where the eyeball is located, and the control unit 150 receives the pattern image Thereby generating a 3D image including the upper and lower eyelid local target regions to which the diagnostic and treatment light sources will be irradiated.

5 is a diagram showing a screening diagnostic process (S200).

The screening diagnostic process (S200) is a process for previously determining whether or not the function of the myospasm occurs. 5, in the screening diagnosis process (S200), the controller 150 controls the light source for diagnosing and treating MySchool of the multi-wavelength light source module unit 110 with the eyelid held by the patient, A process of irradiating a light source having a wavelength of 920 to 930 nm to a local target area of the eyelid at a dose of several mW or less and displaying the eyelid image of the patient photographed through the near infrared ray camera unit 120 on the display unit 140 Is performed. The surgeon can roughly diagnose the position and abnormality of myux spring in the near infrared ray image displayed on the display unit 140. [

FIG. 6 is a diagram showing a detailed diagnosis process (S300).

After the diagnosis of the myalobiliary function deterioration is made by the above screening diagnostic process (S200), a detailed diagnosis process (S300) is performed. In detail, the control unit 150 controls the micro-spring diagnostic light source (LD or LED) of the multi-wavelength light source module unit 110 to perform detailed diagnosis of the myalgia function deterioration in step S300 A light source having a wavelength of 920 to 930 nm is irradiated to a local target area of the patient's inverted eyelid at an output of 10 mW or less and a shape of the my spring spring is photographed through the near infrared ray camera unit 120 Infrared light camera unit 120 according to different wavelengths respectively irradiated with light of wavelengths of all the near-infrared ray bands embedded in the wavelength module, and then diagnosed with dry eye syndrome, And functional images are imaged through the photographed images, thereby displaying the eyelid images of the patient, in which the structural image and the functional image of My myosam are combined, to the display unit 140 The deadline.

FIG. 7 is a view showing a functional image for early diagnosis of myalgia function deterioration, which is implemented by irradiating a light source of various wavelengths in the detailed diagnosis process of my spring (S300) and photographing a near infrared ray image with respect to each wavelength, 8 is a diagram showing degradation of MySpace function.

As shown in FIG. 7, it is possible to diagnose the shape of the myospasm and the degree of stiffness of the lipid in the near-infrared photographed image in the detailed diagnosis process of the my spring (S300) by the brightness and the shape of the white region representing the my spring . In addition, as shown in FIG. 8, the region where the region corresponding to the my spring is not present can be diagnosed as the damage to the my spring.

After the detailed diagnosis process (S300), the diagnostic process of the lacrimal gland (S400) is performed to diagnose the decrease of the lacrimal gland function. In the lacrimal gland diagnosis process (S400), the controller 150 controls the lacrimal gland diagnosis light source of the multi-wavelength light source module unit 110 at the location of the lacrimal gland of the patient, And a light source for lacrimal gland diagnosis is irradiated at an output of several mW or less through the probe section 113 to be in direct contact with the vicinity of the lacrimal gland. The light reflected through the tissue in the vicinity of the lacrimal gland and the lacrimal gland is irradiated to the probe section 113), and the control unit 150 analyzes the absorption rate of the detected light by the tears to display the amount of tears of the lacrimal gland as a percentage based on the steady state, Diagnose the function.

In the case where the detailed diagnosis of the myalobiliary gland (S300) and the diagnosis of the glandular gland (S400) are performed as described above and the treatment for the reduction of the myalgia is performed, the mybalium treatment process (S500) is performed.

In step S500, the controller 150 detects a region corresponding to a lesion region corresponding to MySpace Injury in the 3D image as a local target region for treatment. In order to treat lesions, the multi- A light source having a high absorption (for example, 920 to 930 nm) for lipids on the eyelid of the local target lesion region of the patient who has closed his eyes by controlling the light source for treating mybar spring of the module unit 110 is disposed in a range of tens to several hundreds of mW To examine the output of my spring or lip megasseong lipid closure of the hard lipid that is non-contact way to concentrate only Maisuamseum treatment to treat myalpine function.

During the myaloxemia treatment process (S500), a skin temperature control process (S600) using a thermal image by the controller (150) is performed to prevent the skin from being heated or burned.

Fig. 9 is a view showing a thermographic image for treatment of myalgia hypofunction.

Specifically, the control unit 150 controls the thermal imaging camera unit 130 during the mybalance treatment process (S500) to take a thermal image of the inverted eyelid of the patient to be irradiated with light for treating mybar spring . Thereafter, the controller 150 detects the temperature of the skin in the deteriorated image and controls the output of the light source for diagnosis and treatment of the myomas to maintain the temperature at 40 to 45 ° C. As a result, it is possible to prevent accidents such as burns or burns of the skin during treatment of myalgia.

While the present invention has been particularly shown and described with reference to exemplary embodiments thereof, it is to be understood that the invention is not limited to the disclosed exemplary embodiments. It will be apparent to those skilled in the art that various modifications may be made without departing from the scope of the present invention. Accordingly, the true scope of the present invention should be determined by the technical idea of the appended claims.

100: Diagnosis and treatment device for dry eye syndrome
10: 3D Scanner
23: scanning light source unit 20-2: camera
23: scanning light emission end 24: scanning light entrance end
110: Multi-wavelength light source module unit
A, L: Multi-wavelength light source 112: Optical cable
113: probe unit 114: light irradiation unit
115: optical detecting unit 1:
2: rail

Claims (9)

A 3D scanner unit 10 for projecting scanning light on a facial plane on which an eyeball is located for target diagnosis and treatment of dry eye syndrome, and then capturing a pattern image of a local target area to be irradiated with the diagnostic and treatment light source;
A multi-wavelength light source unit 111 for selecting a wavelength of a light source to perform diagnosis or treatment of My spring radiation, varying intensity of a selected wavelength and outputting light of a selected wavelength to the local target area in a noncontact manner, And a lacrimal gland diagnostic probe for detecting light reflected after passing through the biological tissue where the lacrimal gland is located and passing through the eye lumen, A multi-wavelength light source module unit 110 having a light source module 113;
A near infrared ray camera unit 120 for photographing a near infrared ray image of the eyelid irradiated with the light;
A thermal imaging camera unit 130 for photographing a thermal image of the eyelid to detect the temperature of the eye during the treatment of the myospasm;
A display unit 140 for outputting an image of the eyelids and control information; And
Generating a 3D image including a localized region to which the diagnostic and treatment light source is to be irradiated after receiving the pattern image for diagnosis and treatment and generating a 3D image including a region corresponding to the upper and lower eyelids in the 3D image for diagnosis of dry eye syndrome Wavelength light source module unit 110 and controls the wavelength and intensity of the output light of the multi-wavelength light source module unit 110 to be emitted to the target area. The optical signal received by the lacrimal gland diagnosis probe unit 113 is analyzed, And detects a region corresponding to the upper and lower eyelids as a local target region in the 3D image, and measures the wavelength and the intensity of the output light of the multi-wavelength light source unit 111 And a control unit (150) for irradiating the local target region to treat dry eye syndrome,
The multi-wavelength light source unit (111)
To diagnose the tear secretion of the lacrimal gland, a diagnostic light source (laser diode (LD) or light emitting diode (LED)) that outputs light with a high water absorption rate (eg 970 ~ 980nm) (Laser diode (LD) or light-emitting diode (LED)) for the diagnosis and treatment of myxomas, which outputs light having a high absorption coefficient (e.g., 920 to 930 nm) for lipids for lipids,
The control unit 150,
In case of diagnosing MySpace Dysfunction or treating myalgia dysfunction by driving the light sources of different wavelengths according to diagnosis of MySpace Dysfunction and Diagnosis of Lacrimal Dysfunction, light of 920 ~ 930nm is generated Controls the multi-wavelength light source unit 111,
In order to diagnose the functional deterioration of the lacrimal gland, the multi-wavelength light source unit 111 is configured to control the multi-wavelength light source unit 111 to output light having a wavelength of 970 to 980 nm which is maximally absorbed in water. Device.
delete The probe unit according to claim 1, wherein the probe unit (113)
A light irradiating unit 114 for irradiating diagnosis or treatment light of the multi-wavelength light source unit 111 with an eyelid and a light detecting unit 115 for detecting light reflected from the eyelid, Device.
The probe unit according to claim 3,
A light irradiating unit 114 for irradiating the light of the multi-wavelength light source unit 111 with the lid of the lacrimal gland and irradiating the lacrimal gland diagnosis light, and a light detecting unit 115 for detecting light reflected from the eyelid, In the case where the light source of the multi-wavelength light source unit 111 is a light source of a beam combiner type, an optical cable 112 for guiding the emitted light to directly contact the eyelid where the lacrimal gland is placed is connected to the support base 1 for supporting the head, Wherein the light source is located on a support (1) supporting the head and is directly irradiated when using a multi-wavelength light source in the form of a three-dimensional light source.
The probe unit according to claim 4,
The light irradiation unit 114 and the light detection unit 115 are spaced 5 to 10 mm apart so that the light irradiation unit 114 and the light detection unit 115 are installed to be movable along the rail 2 from the support base 1 supporting the head so as to be selectively applied to both eyes. The target of diagnosis and treatment of dry eye syndrome through stereoscopic awareness.
The apparatus of claim 1, wherein the controller (150)
Wavelength light source 111 to be irradiated with an output power of 10 mW or less when irradiating light for diagnosing lacrimal gland and diagnosing my-spring radiation when irradiating a light source for my- The diagnostic device for dry eye syndrome.
The apparatus of claim 1, wherein the controller (150)
In the treatment of my spring spring, a light source having a wavelength for treating myalbumin is maintained at an output of 10 to 100 mW so that the temperature of the eyelid region to be treated is maintained at 40 to 45 ° C by using an image captured by the thermal imaging camera unit 130 Wavelength light source unit (111) so as to control the output of the multi-wavelength light source unit (100) in a range of a predetermined range.
The method according to claim 1,
The 3D scanner unit 10 projects the scanning light of the 3D scanner unit 10 onto the front face of the face where the eyeball is positioned and then captures the pattern image to generate and transmit the pattern image, and the control unit 150 receives the pattern image, And an upper and lower eyelid 3D local target area image to which the treatment light source is to be irradiated,
The control unit 150 controls the light source for myuxiliary eye diagnosis of the multi-wavelength light source module unit 110 in a state in which the eyelid is wrapped around the patient so that the function of the myal spring can be diagnosed in advance, A screen for illuminating the local target area with light having a wavelength of 920 to 930 nm and displaying the eyelid image of the patient photographed through the near infrared ray camera unit 120 on the display unit 140,
When the myopic function is detected in the near infrared ray eyelid image displayed on the display unit 140 through the screening, the controller 150 controls the multi-wavelength light source module unit 110 (LD or LED) of the myomasum diagnosis light source (LD or LED) of the patient's eye to irradiate a light source having a wavelength of 920 to 930 nm to an output of 10 mW or less in the local target area of the inverted eyelid of the patient, (I.e., a structural image), the light of all wavelengths of the near-infrared band embedded in the multi-wavelength module is irradiated, the infrared rays are photographed through the near-infrared ray camera unit 120 according to different wavelengths, Diagnosis of dry eye syndrome was performed to detect the lesion area and functional image was imaged through the photographed images. The eyelid image of the patient is displayed on the display unit 140,
The control unit 150 detects a region corresponding to the eyelid region detected in the 3D image as a local target region and controls the light source for treating mybar spring in the multi-wavelength light source module unit 110 for treatment of myalgia deficiency Myo-spring is a non-contact type focused intensive treatment of light sources with high absorption (eg, 920 to 930nm) on the eyelid of the local target area of the patient with eyes closed, in the range of tens to hundreds of mW. In addition,
The temperature of the eyelid of the patient whose eyes are closed by the thermal imaging camera unit 130 is monitored by a thermal imaging camera while the controller 150 measures the temperature of the skin of the deteriorated image And the skin temperature control for controlling the output power of the light source for treating mybar spring to maintain the temperature at 40 to 45 ° C.
The method of claim 8,
The controller 150 controls the light source for diagnosing the lacrimal gland of the multi-wavelength light source module unit 110 at the location where the lacrimal gland of the patient is located, so that the probe unit 113 located on the support for supporting the head And a light source for lacrimal gland diagnosis is irradiated at an output of several mW or less, and light reflected through the tissue in the vicinity of the lacrimal gland and the lacrimal gland is irradiated to the probe part The amount of tears of the lacrimal gland is expressed as a percentage based on the steady state by analyzing the absorption rate of the detected tear of the light detected by the controller 150 through the photodetection unit 115 located in the lacrimal gland 113, The diagnostic apparatus for target dry eye syndrome through stereoscopic recognition that performs diagnosis of tear glands to diagnose the function of the eye.

Images